Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

South Korea — Ministry of Food and Drug Safety

Tracked across 3 events · 20 articles · First seen May 26, 2026 · Last active Aug 19, 2026

Sentiment
13
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Business
Impact: The South Korea — Ministry of Food and Drug Safety granted the marketing authorization for eptinezumab in South Korea.
May 26, 2026 · 7 articles
4 0
Regulatory
Impact: The South Korea — Ministry of Food and Drug Safety in South Korea granted the Orphan Drug Designation and Global Innovative Products on Fast Track designation to AGAMREE, which will expedite its regulatory review.
Jun 02, 2026 · 6 articles
4 40
Business
Lundbeck reported strong financial results for the first half of 2026, with total revenue growing 16% CER to DKK 13,588 million, driven by strong performance of Eptinezumab and Brexpiprazole. Adjusted EBITDA rose 19% CER to…
Impact: Granted marketing authorization for eptinezumab in South Korea, expanding market access.
Jul 20, 2026 · 7 articles
ERGEN INTELLIGENCE
Track South Korea — Ministry of Food and Drug Safety live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.